Medical Science Liaisons
Specialized MSLs Reach Specialized Stakeholders
To respond to demand from numerous stakeholder types for higher quality, fair-balanced and evidence-based communications, TMAC has introduced specialized MSL teams that target separate and distinct stakeholder groups:
- CSs (Clinical Specialists)
- CTLs (Clinical Trial Liaisons)
- MMLs/MCLs (Managed Markets/Managed Care Liaisons)
- FORMs (Field-based Outcome Research Managers)
To request a consultation, please contact Beth Price at BPrice@TMACmail.com or 678-581-4445.
We implement customized MSL programs unmatched in value.
The Medical Affairs Company (TMAC) recognizes that not all programs are alike and customizes each program to the specific culture, therapeutic area, product lifecycle stage, and stakeholder needs of the client.
TMAC is unique in that we are the only Contract Medical Organization that provides the pharmaceutical industry with both turnkey deployment of MSL teams and seamless access to an array of innovative consultative solutions. No other organization can help you either create a field based medical team from the ground up or optimize the performance of an existing team.
By partnering with TMAC, you can be assured of the following:
- Scientifically robust, compliant and appropriate exchanges
- Efficient use of internal resources, enabling a constant focus on critical milestones
- Experienced and seasoned TMAC management integrated seamlessly into your organization
- Extensive database of viable MSL candidates meeting the specific criteria of your therapeutic area/product portfolio
- Customized and flexible partnership models
- Access to MSL proprietary reporting and knowledge management tools and resources
- Implementation of comprehensive training program including compliance modules
- Ability to strategically deploy highly credentialed MSL teams within 8-10 weeks
- Option to internalize MSLs and program components at the end of the initial term